Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Dengue Clinical Trial

— VIRIMA  

Official title:

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04619823
• Other study ID #: 2019-062
• Status: Recruiting
• Phase: N/A
• Start date: February 15, 2021
• Est. completion date: February 15, 2026

Study information

• Verified date: May 2024
• Source: Institut Pasteur
• Contact: Myrielle Dupont-Rouzeyrol, PhD
• Phone: +687 27 75 30
• Email: mdupont[@]pasteur.nc
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Arboviruses, diseases transmitted to humans by the bite of an insect vector, are a major public health problem, particularly in tropical and sub-tropical countries. In New Caledonia, dengue epidemics are recurrent and may be associated with the co-circulation of other arboviruses such as Zika or chikungunya.

The virological determinants which condition the occurrence of these epidemics may be linked to an increased vectorial competence of the vector mosquito Aedes aegypti for a particular viral isolate. In fact, the Aedes aegypti mosquito is infected by making a blood meal on a person infected with an arbovirus. The virus infects its digestive tract, then spreads throughout the mosquito's body until it reaches its salivary glands. The virus is then present in the saliva and will be injected into the human host during a new blood meal. Some viral variants are best transmitted by Aedes aegypti. In general, the study of this vectorial competence is carried out by experiments in the laboratory during which an artificial blood meal composed of mammalian blood (human, rabbit, etc.) is mixed with a viral stock. Carrying out deported blood meals during which blood collected from patients infected with an arbovirus is used to gorge mosquitoes makes it possible to place oneself in experimental conditions as close as possible to the natural cycle of transmission of arboviruses.

In the human host, cells of the myeloid lineage present in the peripheral blood constitute preferred targets of replication for arboviruses. At the same time, the peripheral blood cells of patients are activated in response to infection and secrete many soluble factors released into the blood of patients. The study of blood samples from patients infected with arboviruses is therefore of prime importance for understanding both the replicative mechanisms of arboviruses but also the immune response they induce.

Description:

Collection of blood samples from adult patients with clinical signs suggestive of arbovirus

This study is a interventional study that present minimal risks and constraints.

This study will improve :

• the reliability of the results of vector competence experiments

• the understanding of the mechanisms of infection and replication of arboviruses

• the knowledge of the immune mechanisms involved in the response to infection by an arbovirus

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 250
• Est. completion date: February 15, 2026
• Est. primary completion date: February 15, 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Major patient

• Patient with clinical signs suggestive of an arbovirus infection:

Fever And at least 2 clinical signs suggestive of arbovirus among which myalgia, retro-orbital pain, drop in platelets (if data available), digestive symptoms, etc.

• Appearance of clinical signs suggestive of an arbovirus infection in the 7 days preceding the blood sample.

• Patient informed of the performance of the research, the collection of data and biological samples

• Patient who has given their consent to participate in the research by authorizing the collection of data, the collection of an additional blood sample and the use of this sample

Exclusion Criteria:

• Patient suffering from another identified virosis, an inflammatory disease or taking anti-inflammatory drugs

• Pregnant patient

• Patient returning from a trip within 15 days before the onset of the signs,

• Patient for whom the blood sample is incomplete or could not be performed

• Patient's condition, which, in the doctor's opinion, is incompatible with the additional sample required by the study

• Patient not having consented to participate in the research

Related Conditions & MeSH terms

• Arbovirus Infections
• Chikungunya
• Communicable Diseases
• Dengue
• Infections
• Zika

Intervention

Other:
• Blood sample collection
Blood sample collection Mosquito collection at home

Locations

Country	Name	City	State
New Caledonia	Centre Hospitalier Territorial de Nouvelle-Calédonie	Dumbéa Sur Mer

Sponsors (3)

Lead Sponsor	Collaborator
Institut Pasteur	Centre Hospitalier Territorial de Nouvelle-Calédonie, Institut Pasteur de Nouvelle-Calédonie

Country where clinical trial is conducted

New Caledonia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measurement of vector competence parameters of Aedes aegypti (carriers or not of Wolbachia) for arboviruses by vector competence experiments using deported blood meals.	Rate of infection of Aedes aegypti (carriers or not of Wolbachia) for arboviruses	5 years
Primary	Measurement of vector competence parameters of Aedes aegypti (carriers or not of Wolbachia) for arboviruses by vector competence experiments using deported blood meals.	Measurement of dissemination of Aedes aegypti (carriers or not of Wolbachia) for arboviruses	5 years
Primary	Measurement of vector competence parameters of Aedes aegypti (carriers or not of Wolbachia) for arboviruses by vector competence experiments using deported blood meals.	Measurement of transmission of Aedes aegypti (carriers or not of Wolbachia) for arboviruses	5 years
Secondary	Molecular characterization of arborviruses strains included in the blood of patients and which may be diffused by mosquitoes carrying Wolbachia or not during deported blood meals	Whole genome sequencing and bioinformatics techniques as well as by in vitro infections of arbovirus strains included in the blood of patients and which may be diffused by mosquitoes carrying Wolbachia or not during deported blood meals	5 years
Secondary	Molecular characterization of arborviruses strains contained in mosquitoes present in patients' homes	Whole genome sequencing and bioinformatics techniques as well as by in vitro infections of arbovirus strains contained in mosquitoes present in patients' homes	5 years